Los Angeles Capital Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $44.6M | Sell |
689,915
-406,001
| -37% | -$28.6M | 0.18% | 115 |
|
|
2025
Q4 | $70.8M | Buy |
1,095,916
+14,842
| +1% | +$998K | 0.24% | 78 |
|
|
2025
Q3 | $79.3M | Buy |
1,081,074
+107,404
| +11% | +$7.13M | 0.27% | 72 |
|
|
2025
Q2 | $50.7M | Buy |
973,670
+881,094
| +952% | +$50.1M | 0.19% | 103 |
|
|
2025
Q1 | $5.91M | Buy |
92,576
+101
| +0.1% | +$5.87K | 0.03% | 263 |
|
|
2024
Q4 | $4.42M | Sell |
92,475
-18,155
| -16% | -$931K | 0.02% | 339 |
|
|
2024
Q3 | $6.33M | Sell |
110,630
-5,642
| -5% | -$323K | 0.03% | 291 |
|
|
2024
Q2 | $6.09M | Sell |
116,272
-4,728
| -4% | -$207K | 0.02% | 312 |
|
|
2024
Q1 | $4.92M | Buy |
121,000
+17,716
| +17% | +$664K | 0.02% | 348 |
|
|
2023
Q4 | $3.82M | Buy |
103,284
+1,987
| +2% | +$74.8K | 0.01% | 369 |
|
|
2023
Q3 | $3.87M | Buy |
101,297
+9,829
| +11% | +$403K | 0.02% | 342 |
|
|
2023
Q2 | $3.3M | Buy |
91,468
+18,388
| +25% | +$627K | 0.01% | 381 |
|
|
2023
Q1 | $2.79M | Sell |
73,080
-79,308
| -52% | -$3.72M | 0.01% | 427 |
|
|
2022
Q4 | $8.67M | Sell |
152,388
-28,765
| -16% | -$1.47M | 0.04% | 298 |
|
|
2022
Q3 | $7.16M | Sell |
181,153
-14,460
| -7% | -$639K | 0.04% | 309 |
|
|
2022
Q2 | $8.61M | Buy |
195,613
+1,744
| +0.9% | +$75.4K | 0.04% | 288 |
|
|
2022
Q1 | $7.73M | Hold |
193,869
| – | – | 0.03% | 298 |
|
|
2021
Q4 | $7.79M | Buy |
193,869
+124,880
| +181% | +$4.66M | 0.03% | 301 |
|
|
2021
Q3 | $2.81M | Buy |
68,989
+14,565
| +27% | +$609K | 0.01% | 449 |
|
|
2021
Q2 | $2.47M | Sell |
54,424
-15,021
| -22% | -$665K | 0.01% | 541 |
|
|
2021
Q1 | $2.9M | Sell |
69,445
-44,216
| -39% | -$2.02M | 0.01% | 522 |
|
|
2020
Q4 | $4.85M | Buy |
113,661
+1,780
| +2% | +$64K | 0.02% | 399 |
|
|
2020
Q3 | $2.94M | Sell |
111,881
-31,596
| -22% | -$880K | 0.01% | 463 |
|
|
2020
Q2 | $3.85M | Buy |
143,477
+1,466
| +1% | +$33.1K | 0.02% | 451 |
|
|
2020
Q1 | $2.56M | Buy |
142,011
+66,243
| +87% | +$1.26M | 0.02% | 478 |
|
|
2019
Q4 | $1.34M | Sell |
75,768
-75,281
| -50% | -$1.3M | 0.01% | 752 |
|
|
2019
Q3 | $2.34M | Sell |
151,049
-59,265
| -28% | -$976K | 0.01% | 585 |
|
|
2019
Q2 | $3.61M | Sell |
210,314
-62,025
| -23% | -$1M | 0.02% | 511 |
|
|
2019
Q1 | $4.38M | Sell |
272,339
-3,050
| -1% | -$49.4K | 0.02% | 460 |
|
|
2018
Q4 | $4.03M | Buy |
275,389
+40,435
| +17% | +$645K | 0.03% | 410 |
|
|
2018
Q3 | $4.27M | Buy |
234,954
+158,240
| +206% | +$2.77M | 0.02% | 484 |
|
|
2018
Q2 | $1.29M | Sell |
76,714
-4,440
| -5% | -$83.9K | 0.01% | 821 |
|
|
2018
Q1 | $1.59M | Buy |
81,154
+27,570
| +51% | +$534K | 0.01% | 706 |
|
|
2017
Q4 | $1.09M | Buy |
53,584
+40,534
| +311% | +$745K | 0.01% | 838 |
|
|
2017
Q3 | $227K | Buy |
+13,050
| New | +$177K | ﹤0.01% | 1224 |
|
|
2014
Q1 | – | Sell |
-22,450
| Closed | -$337K | – | 1270 |
|
|
2013
Q4 | $337K | Sell |
22,450
-4,290
| -16% | -$55.2K | ﹤0.01% | 1048 |
|
|
2013
Q3 | $295K | Buy |
+26,740
| New | +$223K | ﹤0.01% | 1087 |
|
Other funds holding HALO
VCM
VPM
Los Angeles Capital Management's HALO Position: Q1 2026 in Review
Los Angeles Capital Management reduced its Halozyme (HALO) stake by 37% in Q1 2026, selling an estimated $28.6M and leaving 689,915 shares worth $44.6M. The position accounts for 0.18% of the portfolio, ranked #115.
Los Angeles Capital Management first reported a position in HALO in Q3 2013 and has held it in 37 quarters since. The position peaked at $79.3M in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Los Angeles Capital Management held 689,915 shares of Halozyme worth $44.6M as of Q1 2026.
- Los Angeles Capital Management sold 406,001 Halozyme shares in Q1 2026, an estimated $28.6M.
- Halozyme made up 0.18% of Los Angeles Capital Management's portfolio in Q1 2026, its #115 holding.
- Los Angeles Capital Management first reported a position in Halozyme in Q3 2013 and has held it in 37 quarters since.
- Los Angeles Capital Management's Halozyme position peaked at $79.3M in Q3 2025.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.